Decoy Therapeutics is trading 5.5% down at $4.10 as shares consolidate following a sharp multi-day rebound from its July 27 plunge.
- The move comes despite a lack of new company-specific news, suggesting the decline is a technical pullback after recent sentiment-driven volatility.
- Today's weakness appears stock-specific, as broader biotech and equity markets are currently trading higher.